Mycobacterium celatum encephalitis in an immunocompromised host mimicking autoimmune striatal encephalitis: the first case report
Authors:
- Thanapoom TaweepholTTThanapoom Taweephol
- Thanakit PongpitakmethaThanakit Pongpitakmetha
- Prakit AnukoolwittayaPAPrakit Anukoolwittaya
- Chayoot MarukatatCMChayoot Marukatat
- Wanakorn RattanawongWRWanakorn Rattanawong
- Pasin HemachudhaPHPasin Hemachudha
- Jakapat VanichananJVJakapat Vanichanan
- Suwatchareeporn RotcheewaphanSRSuwatchareeporn Rotcheewaphan
- Abhinbhen W. SarayaASAbhinbhen W. Saraya
Open Access
- 6 March 2025
- journal article
- case report
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 25 (1) , 1-6
Abstract
Encephalitis is rarely caused by nontuberculous mycobacteria (NTM), which is generally not considered a highly virulent pathogen. However, NTM encephalitis in immunocompromised hosts occurs with varied clinical presentations, posing a diagnostic challenge in clinical practice. This study aims to describe an atypical case of NTM encephalitis caused by Mycobacterium celatum, which has not previously been reported to infect the central nervous system of immunocompromised hosts, mimicking autoimmune striatal encephalitis (ASE). A 35-year-old immunosuppressed woman presented with prolonged fever for 4 months and rapidly progressive cognitive decline for 3 months. Neurological examination showed impaired cognition and parkinsonism. Laboratory testing was unremarkable. Her brain imaging on T2-weighted fluid-attenuated inversion recovery (T2/FLAIR) exhibited lesions involving basal ganglia and subcortical white matter in both hemispheres, mimicking ASE. Cerebrospinal fluid (CSF) analysis revealed mild pleocytosis with normal glucose and protein levels. CSF comprehensive microbiological studies and autoimmune panels were negative. ASE was suspected, and immunotherapies were given. Despite immunotherapies, her condition worsened with seizures, warranting a stereotactic brain biopsy to achieve a definite diagnosis. Her brain tissue pathology result was non-specific. However, we identified M. celatum from her brain tissue. Thus, the final diagnosis was M. celatum encephalitis. Therefore, we discontinued immunotherapies and started anti-NTM treatment, including isoniazid, rifampicin, ethambutol, and levofloxacin. After completing a 16-month treatment course, her clinical condition was stable, afebrile, and seizure-free. We proposed that NTM invades the central nervous system and also triggers immune dysregulation, developing features resembling ASE. In case of suspicious autoimmune encephalitis with poor response to immunotherapies, a tissue biopsy should be performed to exclude chronic infection.Keywords
This publication has 19 references indexed in Scilit:
- Leukoencephalopathy resolution after atypical mycobacterial treatment: a case reportBMC Neurology, 2015
- Disseminated Mycobacterium celatum disease with prolonged pulmonary involvementInternational Journal of Infectious Diseases, 2014
- Antimicrobial Susceptibility Testing, Drug Resistance Mechanisms, and Therapy of Infections with Nontuberculous MycobacteriaClinical Microbiology Reviews, 2012
- Penetration of Drugs through the Blood-Cerebrospinal Fluid/Blood-Brain Barrier for Treatment of Central Nervous System InfectionsClinical Microbiology Reviews, 2010
- Mycobacteria-Induced Suppression of Autoimmunity in the Central Nervous SystemJournal of Neuroimmune Pharmacology, 2010
- Acute Disseminated Encephalomyelitis Associated with Meningitis due to Mycobacterium intracellulareInternal Medicine, 2010
- Synergistic interaction between Toll-like receptor agonists is required for induction of experimental autoimmune encephalomyelitis in Lewis ratsJournal of Neuroimmunology, 2007
- Mycobacterium celatum Pulmonary Infection in the Immunocompetent: Case Report and ReviewEmerging Infectious Diseases, 2003
- Virulence and drug susceptibility of Mycobacterium celatumMicrobiology, 2000
- Mycobacterium celatum as a cause of disseminated infection in an AIDS patient.1997